A novel artificial intelligence protocol to investigate potential leads for diabetes mellitus.
Sign Up to like & getrecommendations! Published in 2021 at "Molecular diversity"
DOI: 10.1007/s11030-021-10204-8
Abstract: Dipeptidyl peptidase-4 (DPP4) is highly participated in regulating diabetes mellitus (DM), and inhibitors of DPP4 may act as potential DM drugs. Therefore, we performed a novel artificial intelligence (AI) protocol to screen and validate the… read more here.
Keywords: medicine; intelligence protocol; diabetes mellitus; novel artificial ... See more keywords